Department of Respiratory Medicine and Thoracic Surgery, Institute for Lung Health, Glenfield Hospital, Leicester, United Kingdom.
Ann Am Thorac Soc. 2013 Dec;10 Suppl:S143-9. doi: 10.1513/AnnalsATS.201306-168AW.
Our understanding of the clinical implications of eosinophilic airway inflammation has increased significantly over the last 20 years, aided by the development of noninvasive means to assess it. This pattern of airway inflammation can occur in a diverse range of airway diseases. It is associated with a positive response to corticosteroids and a high risk of preventable exacerbations. Our new understanding of the role of eosinophilic airway inflammation has paved the way for the clinical development of a number of more specific inhibitors that may become new treatment options. Different definitions, ideas of disease, and adoption of biomarkers that are not well known are necessary to fully realize the potential of these treatments.
在过去的 20 年中,我们对嗜酸性气道炎症的临床意义的理解有了显著提高,这得益于非侵入性评估手段的发展。这种气道炎症模式可以发生在多种不同的气道疾病中。它与对皮质类固醇的阳性反应和可预防的加重风险高有关。我们对嗜酸性气道炎症作用的新认识为许多更具特异性的抑制剂的临床开发铺平了道路,这些抑制剂可能成为新的治疗选择。为了充分发挥这些治疗方法的潜力,需要有不同的定义、疾病概念和采用尚未广为人知的生物标志物。